Paving the Way for New Treatments

A University of Missouri researcher has created a computer program that can unravel the mysteries of how proteins work together - giving scientists valuable insights to better prevent, diagnose and treat cancer and other diseases.

Jianlin "Jack" Cheng from Mizzou's College of Engineering and his student, Nabin Giri, have developed a tool called Cryo2Struct that uses artificial intelligence (AI) to build the three-dimensional atomic structure of large protein complexes, work recently published in Nature Communications. The model uses data from pictures of frozen molecules captured by powerful microscopes, or cryo-electron microscopy (cryo-EM) images.

"Cryo-EM right now is a revolutionary, key technology for determining large protein structures and assemblies in cells," said Cheng, a Curators' Distinguished Professor of Electrical Engineering and Computer Science. "But building protein structures from Cryo-EM data is labor intensive and requires a lot of human intervention, making it time-consuming and hard to reproduce. Our technique is fully automated and generates more accurate structures than existing methods."

To understand the significance of the work you have to know a bit about proteins and the decades-old struggle to understand them.

Proteins are the building blocks of life. They start as strings of amino acids that fold into three-dimensional shapes. Those shapes determine how a protein will function.

For more than 50 years, that folding process baffled researchers.

Cheng was among the first to apply deep learning, a type of AI, to the problem. In 2012, he demonstrated an AI-based model that proved deep learning could predict protein structures. The work paved the way for groundbreaking advancements, including Google’s AlphaFold, now considered the most accurate tool in the world for predicting protein structures.

But predicting a single protein structure is only half of the problem. In the real world, proteins work together as molecular machines that carry out complicated biological functions. Understanding protein interactions is critical because they determine how diseases develop and help scientists figure out how best to treat them.

Cheng's Cryo2Struct operates a little like a detective cracking a case without any clues.

The system analyzes cryo-EM images and identifies the individual atoms and their positions within a protein complex, even when there’s no prior knowledge of the structure. The system can then assemble these atoms into a complete 3D model of protein complexes, providing insights into how proteins function.

"Our technology enables scientists to determine and build a structure from cryo-EM data," Cheng said. "Once you have that structure and understand its functions, you can design drugs to counter any faulty functions of a protein complex to make it function properly."

In a related paper published in Chemistry Communications, Cheng and his student, Alex Morehead, explored a different AI method called diffusion model, modeling how molecular structures evolve from random noise into well-defined shapes. Those methods can help scientists generate and optimize small molecules, including drugs, and determine how and where those drugs bind to proteins.

"For instance, I have a drug, and I want to make it work better for some patients," Cheng said. "Now I can use AI to change it and optimize it."

Mizzou's interdisciplinary resources helped make the breakthrough possible. Cheng is a researcher at NextGen Precision Health, where he has access to Cryo-EM and high-resolution electron microscopy.

"The opportunities at Mizzou to collaborate with other researchers and utilize state-of-the-art equipment are unparalleled," he said. "At NextGen, we’re all working to advance highly individualized health care, and technologies like Cryo2Struct will help make that possible."

Giri N, Cheng J.
De novo atomic protein structure modeling for cryoEM density maps using 3D transformer and HMM.
Nat Commun. 2024 Jun 29;15(1):5511. doi: 10.1038/s41467-024-49647-6

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...